Quantcast

Latest colitis Stories

2014-09-18 04:21:05

Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC). Dr. Daniel Teper, Chairman and CEO of Immune comments: "Bertilimumab is...

2014-08-20 16:23:24

NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Acclaimed Actress Amy Brenneman may play a silenced police chief's wife in her new role on "The Leftovers," but she generously lends her voice to help raise awareness for Crohn's disease and ulcerative colitis in a newly refreshed public service awareness campaign. To view the multimedia assets associated with this release, please click...

2014-08-20 08:28:32

The Crohn's & Colitis Foundation of America Teams Up with Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Inflammatory Bowel Disease NEW YORK, Aug. 20, 2014 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) announces an agreement with Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) to identify and support the potential development and translation of research in the area of inflammatory bowel disease...

2014-08-14 04:21:51

CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Aug. 14, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP"), announced today its operating results for the quarter ended June 30, 2014. Dr. Daniel Teper, Chief Executive Officer of Immune Pharmaceuticals, Inc., stated: "Following the completion of a $10.2 million capital raise in March 2014, in the second quarter, we have been able to advance the preparation of Phase II clinical trials...

2014-08-12 08:31:26

Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4...

2014-08-01 08:26:41

NEW YORK, Aug. 1, 2014 /PRNewswire/ -- Beginning on August 1, 2014, Crohn's and Colitis Awareness Month will be observed for the first time in New York State thanks to a resolution passed by the New York State legislature in June, reported the Crohn's & Colitis Foundation of America (CCFA). There are more than 1.4 million Americans living with Crohn's disease and ulcerative colitis, which are known collectively as inflammatory bowel diseases (IBD). "We applaud Governor Andrew...

2014-07-31 23:23:12

A new memoir by Zoe Chloe Douglas, now available in e-book and hardcover versions, documents one woman’s experience with Ulcerative Colitis, a common autoimmune disorder. San Diego, CA (PRWEB) July 31, 2014 "The Mirror Inside: A Journey to Finding Answers to Ulcerative Colitis from Within" by Zoe Chloe Douglas can be downloaded for Kindle at http://amzn.to/1nUxRa3, purchased in hardcover format at http://amzn.to/Uywu5H or downloaded for Barnes & Noble Nooks at...

2014-07-29 16:26:15

Researchers Look to Target Gut Microbiome for Treatment and Prevention of Crohn's Disease and Ulcerative Colitis NEW YORK, July 29, 2014 /PRNewswire/ -- Early findings from a major research initiative of the Crohn's & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the...

2014-07-23 08:27:58

What Will Your Challenge Be? NEW YORK, July 23, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America's endurance training and fundraising program, Team Challenge, is thrilled to unveil its upcoming race portfolio with 11 great endurance events scheduled this winter including: -- TriRock San Diego - September 21 -- IRONMAN Chattanooga - September 28 -- Chicago Marathon - October 14 (limited entries) -- New York Marathon - November 1 (limited entries) --...

2014-07-18 08:25:11

Take Steps Walk Program Helps Fund Key Initiatives for CCFA NEW YORK, July 18, 2014 /PRNewswire-USNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives. It's fundraising...


Latest colitis Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related